Powered by
GROSSE POINTE FARMS–SciTech Development Inc., a clinical-stage oncology drug development company, announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (IND) application for a Phase …
NOVI—Officials at Delphinus Medical Technologies Inc. announced that the U.S. Food and Drug Administration has granted premarket approval of its SoftVue 3D Whole Breast Ultrasound Tomography System. The system is …
KALAMAZOO—Officials at Stryker Corp., the Kalamazoo medical device maker, announced the company has received U.S. Food and Drug Administration approval for an expanded indication of its Neuroform Atlas Stent System, …
ANN ARBOR—Esperion Therapeutics Inc. (NASDAQ:ESPR) announced that the U.S. Food and Drug Administration (FDA) approved Nexletol (bempedoic acid) tablet, an oral, once-daily, non-statin cholesterol-lowering medicine. Nexletol is indicated as an …